Corient Private Wealth
MRVI icon

Corient Private Wealth’s Maravai LifeSciences MRVI Stock Holding History

Corient Private Wealth’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,050
Closed -$212K – 2204
2023
Q2 		$212K Buy
+17,050
New +$230K ﹤0.01% 1848

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Corient Private Wealth's MRVI Position: Q3 2023 in Review

Corient Private Wealth sold out of Maravai LifeSciences (MRVI) in Q3 2023, closing a stake of 17,050 shares — an estimated $212K sold.

Corient Private Wealth first reported a position in MRVI in Q2 2023 and held it in 1 quarter. The position peaked at $212K in Q2 2023. 204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

  • Corient Private Wealth reported no remaining Maravai LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Corient Private Wealth sold 17,050 Maravai LifeSciences shares in Q3 2023, an estimated $212K.
  • Corient Private Wealth first reported a position in Maravai LifeSciences in Q2 2023 and held it in 1 quarter.
  • Corient Private Wealth's Maravai LifeSciences position peaked at $212K in Q2 2023.
  • 204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on Corient Private Wealth's 13F filing for Q3 2023, filed 3 Nov 2023.